www.fdanews.com/articles/175510-high-court-shows-little-enthusiasm-for-lowering-patent-damages-standards
![](https://www.fdanews.com/ext/resources/test/Drug-Images3/GavelinfrontofBooks.gif?t=1434643836&width=430)
High Court Shows Little Enthusiasm for Lowering Patent Damages Standards
February 29, 2016
In a case with broad implications for medical patent protection, the U.S. Supreme Court showed little enthusiasm for lowering a strict appellate standard for enhanced damages during oral arguments last week.
The eight justices considered a consolidated case involving two instances of patent infringement, both of which challenged the federal appellate courts’ two-part test to determine whether an infringement is willful, thereby opening a patent violator up to triple compensatory damages.
The justices sharply questioned both sides in the case but expressed a clear reticence toward dismantling the existing standard.